News
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
Alphabet spinoff SandboxAQ is teaming up with iOncologi to build a new mRNA vaccine for a common and aggressive brain tumor ...
RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers ...
We're delighted to announce $6.5 million in philanthropic investments from the Colonial Foundation and philanthropist, David Russell, to supercharge ...
Under President Donald Trump, the GOP has decided to go nuclear. The federal government’s support of science and medicine is being systematically destroyed by devastating cuts to research, agencies ...
Explore cutting-edge technologies and workflows advancing downstream processing in biopharma, driving purification efficiency ...
SandboxAQ and iOncologi today announced a strategic collaboration to jointly develop, validate, and commercialize a novel high-fidelity mRNA vaccine for glioblastoma, the most common and aggressive ...
Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...
European Medicines Agency Supports Streamlined Development Pathway for GEO-MVA Vaccine Candidate via a Single Phase 3 Immuno-bridging Trial ATLANTA, GA - July 16, 2025 (NEWMEDIAWIRE) - GeoVax Labs, ...
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – Budget cuts are on the horizon for ...
In this week’s edition of InnovationRx, we look at how Daniel Nadler became a billionaire building a ChatGPT for doctors, big news from two Chinese biotech companies, what doctors think about AI and ...
Yet, even as we celebrate these strengths, it is clear that the next phase of growth will not be driven by volume alone. To remain globally competitive and meet the complex health needs of the future, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results